## Abstract This research evaluated the controlled release of glial‐derived neurotrophic factor (GDNF) from an affinity‐based delivery system (ABDS) as potential treatment for peripheral nerve injury. The ABDS consisted of a bidomain peptide containing a transglutaminase substrate, allowing crossli
✦ LIBER ✦
Affinity-based release of glial-derived neurotrophic factor from fibrin matrices enhances sciatic nerve regeneration
✍ Scribed by Matthew D. Wood; Amy M. Moore; Daniel A. Hunter; Sami Tuffaha; Gregory H. Borschel; Susan E. Mackinnon; Shelly E. Sakiyama-Elbert
- Book ID
- 103999554
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 776 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1742-7061
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Controlled release of glial-derived neur
✍
Matthew D. Wood; Gregory H. Borschel; Shelly E. Sakiyama-Elbert
📂
Article
📅
2009
🏛
John Wiley and Sons
🌐
English
⚖ 250 KB
👁 1 views
Release rate controls biological activit
✍
Matthew D. Wood; Shelly E. Sakiyama-Elbert
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 317 KB
👁 1 views
## Abstract Previously, combinatorial techniques were used to identify peptide sequences exhibiting high, medium, and low affinity for heparin. Bidomain peptides were synthesized containing a transglutaminase sequence for one domain and one of the heparin‐affinity sequences for the other domain. A